C171H168ClF2N21O22S7 — CID 157091488
[4-[(2-tert-butylsulfanylphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(3-chloro-4-fluorophenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(2-fluoro-6-methoxyphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]-N-methylquinoline-8-sulfonamide;[4-(2-methoxyphenyl)piperazin-1-yl]-[5-(quinolin-8-ylsulfonylmethyl)-2-pyridinyl]methanone;[4-(2-methoxyphenyl)piperazin-1-yl]-[6-(quinolin-8-ylsulfonylmethyl)-3-pyridinyl]methanone (PubChem CID 157091488) has the molecular formula C171H168ClF2N21O22S7 and a molecular weight of 3167.27 g/mol. Its IUPAC name is [4-[(2-tert-butylsulfanylphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(3-chloro-4-fluorophenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(2-fluoro-6-methoxyphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]-N-methylquinoline-8-sulfonamide;[4-(2-methoxyphenyl)piperazin-1-yl]-[5-(quinolin-8-ylsulfonylmethyl)-2-pyridinyl]methanone;[4-(2-methoxyphenyl)piperazin-1-yl]-[6-(quinolin-8-ylsulfonylmethyl)-3-pyridinyl]methanone.
| Compound Name | [4-[(2-tert-butylsulfanylphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(3-chloro-4-fluorophenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(2-fluoro-6-methoxyphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]-N-methylquinoline-8-sulfonamide;[4-(2-methoxyphenyl)piperazin-1-yl]-[5-(quinolin-8-ylsulfonylmethyl)-2-pyridinyl]methanone;[4-(2-methoxyphenyl)piperazin-1-yl]-[6-(quinolin-8-ylsulfonylmethyl)-3-pyridinyl]methanone |
|---|---|
| PubChem CID | 157091488 |
| Molecular Formula | C171H168ClF2N21O22S7 |
| Molecular Weight | 3167.27 g/mol |
| Exact Mass | 3164.04 |
| IUPAC Name | [4-[(2-tert-butylsulfanylphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(3-chloro-4-fluorophenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(2-fluoro-6-methoxyphenyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]-N-methylquinoline-8-sulfonamide;[4-(2-methoxyphenyl)piperazin-1-yl]-[5-(quinolin-8-ylsulfonylmethyl)-2-pyridinyl]methanone;[4-(2-methoxyphenyl)piperazin-1-yl]-[6-(quinolin-8-ylsulfonylmethyl)-3-pyridinyl]methanone |
| SMILES | CC(C)(C)Sc1ccccc1CN1CCN(C(=O)c2ccc(CS(=O)(=O)c3cccc4cccnc34)cc2)CC1.COc1cccc(F)c1CN1CCN(C(=O)c2ccc(CS(=O)(=O)c3cccc4cccnc34)cc2)CC1.COc1ccccc1N1CCN(C(=O)c2ccc(CS(=O)(=O)c3cccc4cccnc34)cn2)CC1.COc1ccccc1N1CCN(C(=O)c2ccc(CS(=O)(=O)c3cccc4cccnc34)nc2)CC1.COc1ccccc1N1CCN(C(=O)c2ccc(N(C)S(=O)(=O)c3cccc4cccnc34)cc2)CC1.O=C(c1ccc(CS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(Cc2ccc(F)c(Cl)c2)CC1 |
| InChI | InChI=1S/C32H35N3O3S2.C29H28FN3O4S.C28H25ClFN3O3S.C28H28N4O4S.2C27H26N4O4S/c1-32(2,3)39-28-11-5-4-8-27(28)22-34-18-20-35(21-19-34)31(36)26-15-13-24(14-16-26)23-40(37,38)29-12-6-9-25-10-7-17-33-30(25)29;1-37-26-8-3-7-25(30)24(26)19-32-15-17-33(18-16-32)29(34)23-12-10-21(11-13-23)20-38(35,36)27-9-2-5-22-6-4-14-31-28(22)27;29-24-17-21(8-11-25(24)30)18-32-13-15-33(16-14-32)28(34)23-9-6-20(7-10-23)19-37(35,36)26-5-1-3-22-4-2-12-31-27(22)26;1-30(37(34,35)26-11-5-7-21-8-6-16-29-27(21)26)23-14-12-22(13-15-23)28(33)32-19-17-31(18-20-32)24-9-3-4-10-25(24)36-2;1-35-24-9-3-2-8-23(24)30-14-16-31(17-15-30)27(32)22-12-11-20(18-29-22)19-36(33,34)25-10-4-6-21-7-5-13-28-26(21)25;1-35-24-9-3-2-8-23(24)30-14-16-31(17-15-30)27(32)21-11-12-22(29-18-21)19-36(33,34)25-10-4-6-20-7-5-13-28-26(20)25/h4-17H,18-23H2,1-3H3;2-14H,15-20H2,1H3;1-12,17H,13-16,18-19H2;3-16H,17-20H2,1-2H3;2*2-13,18H,14-17,19H2,1H3 |
| InChIKey | AESHKXLZLISCAE-UHFFFAOYSA-N |
| XLogP | 26.51 |
| TPSA | 489.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 224 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3167.27 |
| LogP ≤ 5 | 26.51 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 37 |